Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF STEROID TACCOSIDE A IN PREPARING TUMOR IMMUNOTHERAPY DRUG
Document Type and Number:
WIPO Patent Application WO/2024/000812
Kind Code:
A1
Abstract:
Provided is use of a steroid Taccoside A in preparing a tumor immunotherapy drug. The steroid Taccoside A can regulate T lymphocytes of the human immune system to effectively kill various types of tumor cells, including various non-solid tumor cells and solid tumor cells, and the cell viability results show that the survival rates of different types of tumor cells are 10% or below. The steroid Taccoside A can further show the same effective tumor immune killing effect on T lymphocytes from different blood type sources. Moreover, the steroid Taccoside A is a low-toxicity, highly effective tumor immunotherapy molecule that is applicable to a wide range of people and has killing effects on various types of tumor cells.

Inventors:
LUO XIAODONG (CN)
DAI ZHI (CN)
ZHU PEIFENG (CN)
ZHAO YUNLI (CN)
ZHAO LIXING (CN)
Application Number:
PCT/CN2022/117966
Publication Date:
January 04, 2024
Filing Date:
September 09, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV YUNNAN (CN)
International Classes:
A61P35/00; A61K31/7048; A61P35/02; A61P37/02
Domestic Patent References:
WO2018068399A12018-04-19
Other References:
CHEN, KE ET AL.: "Demethylzeylasteral attenuates hepatic stellate cell activation and liver fibrosis by inhibiting AGAP2 mediated signaling", PHYTOMEDICINE, vol. 105, 21 July 2022 (2022-07-21), pages 1 - 14, XP087161565, DOI: 10.1016/j.phymed.2022.154349
LIU, HAIYANG; CHEN, CHANG XIANG: "Two New Steroidal Saponins from Tacca plantaginea", CHINESE CHEMICAL LETTERS, vol. 13, no. 7, 31 December 2002 (2002-12-31), AMSTERDAM, NL , pages 633 - 636, XP009552138, ISSN: 1001-8417
Attorney, Agent or Firm:
BEIJING GAOWO LAW FIRM (CN)
Download PDF: